Organization · Venture Capital
Greater Manchester and Cheshire Life Sciences Fund
The Greater Manchester and Cheshire Life Sciences Fund is a £31 million seed and early-stage venture capital fund focused on life sciences businesses in the Greater Manchester and Cheshire & Warrington region. It is managed by Catapult Ventures and has concluded its new investment period.
Overview
What Greater Manchester and Cheshire Life Sciences Fund does
What Greater Manchester and Cheshire Life Sciences Fund is
The Greater Manchester and Cheshire Life Sciences Fund is a £31 million seed and early-stage venture capital fund focused on life sciences businesses in the Greater Manchester and Cheshire & Warrington region. It is managed by Catapult Ventures and has concluded its new investment period.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find Greater Manchester and Cheshire Life Sciences Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
Greater Manchester and Cheshire Life Sciences Fund as a funder
Investment thesis
The Greater Manchester and Cheshire Life Sciences Fund focuses on backing seed and early-stage life sciences businesses in the Greater Manchester and Cheshire & Warrington region, aiming to build a local life sciences cluster.
Focus narrative
The fund primarily invests in seed and early-stage life sciences businesses, including pharmaceuticals, biotechnology, diagnostics, healthcare technologies, and medical devices. It aims to support companies that are innovating within these sectors and are located in the Greater Manchester and Cheshire & Warrington region.
Value beyond capital
The fund provides not only financial support but also strategic guidance and resources to its portfolio companies, leveraging its network and expertise in the life sciences sector to help them grow and succeed.
Focus and fit
- Stages
- Seed · Friends and Family · Accelerator
- Sectors
- Biotech · Healthcare · Digital Health · Medical Devices
- Regions
- North AmericaEurope
Availability
- Currently deploying
- No
Portfolio and track record
- Recorded portfolio count
- 42
Portfolio context
Bitrobius Genetics: A start-up biotechnology company developing synthetic gene transfer technology. Rinicare: A digital healthcare technology company focused on falls prevention and remote monitoring. Maxwellia: A pharmaceuticals company specializing in switching prescription medicines to over-the-counter products. Monument Therapeutics: A company utilizing digital biomarkers for neuroscience drug development. Blueberry Therapeutics: Developing topical therapies for fungal infections.
Common questions
What to know about Greater Manchester and Cheshire Life Sciences Fund
Upseed classifies Greater Manchester and Cheshire Life Sciences Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.